TurboMist can deliver medication in just three minutes, making it the fastest small-volume nebulizer on the market, Medline says. Traditional nebulizers, meanwhile, can take at least 10 minutes to provide treatment.
Medline designed TurboMist to deliver 2.5 times more medication per minute than a standard nebulizer. It significantly reduces treatment times to provide nearly 70% faster treatment than the standard. The company says this empowers respiratory therapists and clinicians to deliver faster, more cost-effective care.
According to a news release, the nebulizer delivers better deposition, with faster delivery and an optimal respirable fraction to speed patient relief. Faster treatment also means less time holding the device, making for a better, easier experience and improving patient compliance.
Medline says TurboMist’s comfortable swivel mouthpiece helps to reduce mask use and works while sitting or lying face-upwards. Doctors can use it for patients aged five and up in a hospital or home care setting.
“Respiratory therapists are constantly adapting and innovating to solve challenges to better care for patients, and we strive to innovate right beside them in order to strengthen the respiratory therapy sector. Over the years, we have developed robust solutions to meet every respiratory need, from hospital to home,” said James Donegan, a registered respiratory therapist and Medline clinical specialist. “We believe that our newest solution, TurboMist, will fulfill a need in the market to drive efficiencies with shorter medication delivery times and an enhanced patient experience.”
